This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Lupin, Inc.. Active years: 2013-2014.
Company Filing History:
Years Active: 2013-2014
Title: Dabeer Karnalkar: Innovator in Pharmaceutical Processes
Introduction
Dabeer Karnalkar is a notable inventor based in Pune, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of improved processes for drug preparation. With a total of 2 patents, his work showcases innovation and practicality in pharmaceutical applications.
Latest Patents
Karnalkar's latest patents include a process for the preparation of Efavirenz, which presents several advantages over previously reported methods. These advantages include low cost, high yield, better optical purity, and industrial feasibility. Another significant patent is for a polymorph of desvenlafaxine benzoate, which relates to a novel crystalline form L of (±)-desvenlafaxine benzoate. This invention also encompasses the process for preparing this crystalline form and its pharmaceutical composition, which includes one or more pharmaceutically acceptable excipients.
Career Highlights
Dabeer Karnalkar is currently associated with Lupin, Inc., a prominent player in the pharmaceutical industry. His work at Lupin has allowed him to focus on innovative drug development processes that enhance the efficacy and affordability of medications.
Collaborations
Karnalkar has collaborated with notable colleagues, including Gurvinder Pal Singh and Girij Pal Singh. These collaborations have contributed to the advancement of pharmaceutical innovations and the successful development of new drug formulations.
Conclusion
Dabeer Karnalkar's contributions to the pharmaceutical industry through his patents and collaborative efforts highlight his role as an innovator. His work not only improves existing processes but also paves the way for future advancements in drug development.